JP7184373B2 - 生体外での腸管腫瘍の検査方法 - Google Patents
生体外での腸管腫瘍の検査方法 Download PDFInfo
- Publication number
- JP7184373B2 JP7184373B2 JP2020012211A JP2020012211A JP7184373B2 JP 7184373 B2 JP7184373 B2 JP 7184373B2 JP 2020012211 A JP2020012211 A JP 2020012211A JP 2020012211 A JP2020012211 A JP 2020012211A JP 7184373 B2 JP7184373 B2 JP 7184373B2
- Authority
- JP
- Japan
- Prior art keywords
- mucl1
- intestinal
- tumor
- mucin
- tumors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Description
Claims (2)
- ムチン様タンパク質遺伝子Mucl1の発現の上昇を小腸における腸管腫瘍の腫瘍マーカーとして用いることを特徴とする生体外での腸管腫瘍の検査方法。
- 前記腫瘍マーカーは、小腸の近位、中位、遠位のいずれかにおける腸管腫瘍の腫瘍マーカーであることを特徴とする請求項1に記載の生体外での腸管腫瘍の検査方法。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020012211A JP7184373B2 (ja) | 2020-01-29 | 2020-01-29 | 生体外での腸管腫瘍の検査方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020012211A JP7184373B2 (ja) | 2020-01-29 | 2020-01-29 | 生体外での腸管腫瘍の検査方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2021114971A JP2021114971A (ja) | 2021-08-10 |
JP7184373B2 true JP7184373B2 (ja) | 2022-12-06 |
Family
ID=77173268
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020012211A Active JP7184373B2 (ja) | 2020-01-29 | 2020-01-29 | 生体外での腸管腫瘍の検査方法 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7184373B2 (ja) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080233563A1 (en) | 2004-02-27 | 2008-09-25 | Musc Foundation For Research Development | Enhanced Detection of Rna Using a Panel of Truncated Gene-Specific Primers for Reverse Transcription |
JP2012515334A (ja) | 2009-01-14 | 2012-07-05 | ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ | 比に基づく生体マーカーおよびそれを使用する方法 |
-
2020
- 2020-01-29 JP JP2020012211A patent/JP7184373B2/ja active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080233563A1 (en) | 2004-02-27 | 2008-09-25 | Musc Foundation For Research Development | Enhanced Detection of Rna Using a Panel of Truncated Gene-Specific Primers for Reverse Transcription |
JP2012515334A (ja) | 2009-01-14 | 2012-07-05 | ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ | 比に基づく生体マーカーおよびそれを使用する方法 |
Non-Patent Citations (1)
Title |
---|
P5-3ムチン様タンパク質の腫瘍形成における役割,第23回日本がん分子標的治療学会学術集会プログラム・抄録集,2019年05月15日,第112頁 |
Also Published As
Publication number | Publication date |
---|---|
JP2021114971A (ja) | 2021-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wedge et al. | Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets | |
Krug et al. | Pervasive H3K27 acetylation leads to ERV expression and a therapeutic vulnerability in H3K27M gliomas | |
Alzahrani et al. | General insight into cancer: An overview of colorectal cancer | |
Zhang et al. | Weighted gene co-expression network analysis and connectivity map identifies lovastatin as a treatment option of gastric cancer by inhibiting HDAC2 | |
Arnoldussen et al. | Butyrate restores HFD-induced adaptations in brain function and metabolism in mid-adult obese mice | |
Lee et al. | Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasis | |
Ding et al. | SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression | |
Song et al. | 17β-Estradiol supplementation changes gut microbiota diversity in intact and colorectal cancer-induced ICR male mice | |
Zysset-Burri et al. | Associations of the intestinal microbiome with the complement system in neovascular age-related macular degeneration | |
Hu et al. | NOTCH-YAP1/TEAD-DNMT1 axis drives hepatocyte reprogramming into intrahepatic cholangiocarcinoma | |
Yang et al. | Increased survival following tumorigenesis in Ts65Dn mice that model Down syndrome | |
Aarnio | Clinicopathological features and management of cancers in lynch syndrome | |
Place et al. | Hyperplastic-adenomatous polyposis syndrome | |
Breyne et al. | Non-classical proIL-1beta activation during mammary gland infection is pathogen-dependent but caspase-1 independent | |
Sharp et al. | DNA damage response genes mark the early transition from colitis to neoplasia in colitis-associated colon cancer | |
Liu et al. | Long-term survival, quality of life, and molecular features of the patients with solid pseudopapillary neoplasm of the pancreas: a retrospective study of 454 cases | |
JP7184373B2 (ja) | 生体外での腸管腫瘍の検査方法 | |
Chaiyadet et al. | Knockout of liver fluke granulin, Ov-grn-1, impedes malignant transformation during chronic infection with Opisthorchis viverrini | |
Reehorst et al. | EHF is essential for epidermal and colonic epithelial homeostasis, and suppresses Apc-initiated colonic tumorigenesis | |
Rubio | Corrupted colonic crypt fission in carcinogen-treated rats | |
Kashfi et al. | Frameshift mutations (deletion at codon 1309 and codon 849) in the APC gene in Iranian FAP patients: a case series and review of the literature | |
Moran et al. | CDH1 associated gastric cancer: a report of a family and review of the literature | |
Wang et al. | A novel pathogenic splice acceptor site germline mutation in intron 14 of the APC gene in a Chinese family with familial adenomatous polyposis | |
Gao et al. | PDCD4 expression in coronary atherosclerosis rat models and its mechanism | |
Robinson et al. | Kaiso-induced intestinal inflammation is preceded by diminished E-cadherin expression and intestinal integrity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210129 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20211130 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220127 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220215 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220411 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20220705 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220930 |
|
C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20220930 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20221007 |
|
C21 | Notice of transfer of a case for reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C21 Effective date: 20221018 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20221025 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20221116 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7184373 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |